Literature DB >> 17515611

Epigenetic regulation of tumor necrosis factor alpha.

K E Sullivan1, A B M Reddy, K Dietzmann, A R Suriano, V P Kocieda, M Stewart, M Bhatia.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) is a potent cytokine which regulates inflammation via the induction of adhesion molecules and chemokine expression. Its expression is known to be regulated in a complex manner with transcription, message turnover, message splicing, translation, and protein cleavage from the cell surface all being independently regulated. This study examined both cell lines and primary cells to understand the developmental regulation of epigenetic changes at the TNF-alpha locus. We demonstrate that epigenetic modifications of the TNF-alpha locus occur both developmentally and in response to acute stimulation and, importantly, that they actively regulate expression. DNA demethylates early in development, beginning with the hematopoietic stem cell. The TNF-alpha locus migrates from heterochromatin to euchromatin in a progressive fashion, reaching euchromatin slightly later in differentiation. Finally, histone modifications characteristic of a transcriptionally competent gene occur with myeloid differentiation and progress with differentiation. Additional histone modifications characteristic of active gene expression are acquired with stimulation. In each case, manipulation of these epigenetic variables altered the ability of the cell to express TNF-alpha. These studies demonstrate the importance of epigenetic regulation in the control of TNF-alpha expression. These findings may have relevance for inflammatory disorders in which TNF-alpha is overproduced.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515611      PMCID: PMC1951949          DOI: 10.1128/MCB.02429-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Cutting Edge: Innate production of IFN-gamma by NK cells is independent of epigenetic modification of the IFN-gamma promoter.

Authors:  Cristina M Tato; Gislâine A Martins; Frances A High; Catherine B DiCioccio; Steven L Reiner; Christopher A Hunter
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

2.  Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties.

Authors:  Lisheng Wang; Li Li; Farbod Shojaei; Krysta Levac; Chantal Cerdan; Pablo Menendez; Tanya Martin; Anne Rouleau; Mickie Bhatia
Journal:  Immunity       Date:  2004-07       Impact factor: 31.745

3.  Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide.

Authors:  A E Goldfeld; C Doyle; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

5.  A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines.

Authors:  B Beutler; T Brown
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Tumour necrosis factor-alpha (TNF-alpha) in the host resistance to mycobacteria of distinct virulence.

Authors:  R Appelberg; A Sarmento; A G Castro
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

7.  The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines.

Authors:  K L Rhoades; S H Golub; J S Economou
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

8.  Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: role of NF-kappa B.

Authors:  N S Trede; A V Tsytsykova; T Chatila; A E Goldfeld; R S Geha
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

9.  Granulocyte-macrophage colony-stimulating factor and interleukin-4 differentially regulate the human tumor necrosis factor-alpha promoter region.

Authors:  K L Rhoades; S Cai; S H Golub; J S Economou
Journal:  Cell Immunol       Date:  1995-03       Impact factor: 4.868

10.  Extinction of the tumor necrosis factor locus, and of genes encoding the lipopolysaccharide signaling pathway.

Authors:  V Kruys; P Thompson; B Beutler
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  87 in total

Review 1.  Epigenetic mechanisms in inflammation.

Authors:  D Bayarsaihan
Journal:  J Dent Res       Date:  2011-01       Impact factor: 6.116

2.  MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivo.

Authors:  Giuseppina Improta; Cathrin Ritter; Angela Pettinato; Valeria Vasta; David Schrama; Filippo Fraggetta; Jürgen C Becker
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-12       Impact factor: 4.553

Review 3.  Epigenomics, gestational programming and risk of metabolic syndrome.

Authors:  M Desai; J K Jellyman; M G Ross
Journal:  Int J Obes (Lond)       Date:  2015-02-02       Impact factor: 5.095

Review 4.  Immune senescence, epigenetics and autoimmunity.

Authors:  Donna Ray; Raymond Yung
Journal:  Clin Immunol       Date:  2018-04-11       Impact factor: 3.969

5.  G9a and HP1 couple histone and DNA methylation to TNFalpha transcription silencing during endotoxin tolerance.

Authors:  Mohamed El Gazzar; Barbara K Yoza; Xiaoping Chen; Jean Hu; Gregory A Hawkins; Charles E McCall
Journal:  J Biol Chem       Date:  2008-09-22       Impact factor: 5.157

Review 6.  Transcriptional control of the TNF gene.

Authors:  James V Falvo; Alla V Tsytsykova; Anne E Goldfeld
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

7.  Noncoding RNAs and LRRFIP1 regulate TNF expression.

Authors:  Lihua Shi; Li Song; Michael Fitzgerald; Kelly Maurer; Asen Bagashev; Kathleen E Sullivan
Journal:  J Immunol       Date:  2014-02-24       Impact factor: 5.422

8.  BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses.

Authors:  Anna C Belkina; Barbara S Nikolajczyk; Gerald V Denis
Journal:  J Immunol       Date:  2013-02-18       Impact factor: 5.422

Review 9.  Epigenetics and periodontal disease: future perspectives.

Authors:  Ricardo Santiago Gomez; Walderez Ornelas Dutra; Paula Rocha Moreira
Journal:  Inflamm Res       Date:  2009-05-08       Impact factor: 4.575

10.  Global H4 acetylation analysis by ChIP-chip in systemic lupus erythematosus monocytes.

Authors:  Z Zhang; L Song; K Maurer; M A Petri; K E Sullivan
Journal:  Genes Immun       Date:  2009-08-27       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.